Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic‐treated rats

[1]  B. van Ravenzwaay,et al.  Impact of lincosamides antibiotics on the composition of the rat gut microbiota and the metabolite profile of plasma and feces. , 2018, Toxicology letters.

[2]  Wei Jia,et al.  Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis , 2018, Nature Reviews Gastroenterology & Hepatology.

[3]  Mong-Hong Lee,et al.  Dysbiosis of gut microbiota in promoting the development of colorectal cancer , 2017, Gastroenterology report.

[4]  C. Gahan,et al.  Interactions between gut bacteria and bile in health and disease. , 2017, Molecular aspects of medicine.

[5]  M. Slopianka,et al.  Quantitative targeted bile acid profiling as new markers for DILI in a model of methapyrilene-induced liver injury in rats. , 2017, Toxicology.

[6]  R. Evers,et al.  Antibiotic‐Induced Elevations of Plasma Bile Acids in Rats Independent of Bsep Inhibition , 2017, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  T. Hadden,et al.  Bile acid: a potential inducer of colon cancer stem cells , 2016, Stem Cell Research & Therapy.

[8]  P. Cotter,et al.  Short bowel syndrome (SBS)‐associated alterations within the gut‐liver axis evolve early and persist long‐term in the piglet model of short bowel syndrome , 2016, Journal of gastroenterology and hepatology.

[9]  H. Sokol,et al.  Interplay between bile acid metabolism and microbiota in irritable bowel syndrome , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[10]  E. Comelli,et al.  Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease , 2016, PloS one.

[11]  M. Haluzík,et al.  The role of bile acids in metabolic regulation. , 2016, The Journal of endocrinology.

[12]  Bennard van Ravenzwaay,et al.  The development of a database for metabolomics - looking back on ten years of experience , 2016 .

[13]  M. Kibbe,et al.  Vancomycin treatment and butyrate supplementation modulate gut microbe composition and severity of neointimal hyperplasia after arterial injury , 2015, Physiological reports.

[14]  C. Klaassen,et al.  Importance of Large Intestine in Regulating Bile Acids and Glucagon-Like Peptide-1 in Germ-Free Mice , 2015, Drug Metabolism and Disposition.

[15]  A. Olivares-Morales,et al.  Animal versus human oral drug bioavailability: Do they correlate? , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  P. Hylemon,et al.  Bile acids and the gut microbiome , 2014, Current opinion in gastroenterology.

[17]  H. Kamp,et al.  Reproducibility and robustness of metabolome analysis in rat plasma of 28-day repeated dose toxicity studies. , 2012, Toxicology letters.

[18]  M. T. Donato,et al.  Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method[S] , 2012, Journal of Lipid Research.

[19]  H. Sokol,et al.  Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases , 2012, Gut.

[20]  H. Kamp,et al.  Metabolomics: a tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals-from QSAR to QBAR. , 2012, Mutation research.

[21]  H. Kamp,et al.  Increased toxicity when fibrates and statins are administered in combination--a metabolomics approach with rats. , 2012, Toxicology letters.

[22]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[23]  J. Raufman,et al.  Bile Acids Regulate Cardiovascular Function , 2011, Clinical and translational science.

[24]  E. Want,et al.  Colonization-Induced Host-Gut Microbial Metabolic Interaction , 2011, mBio.

[25]  T. Sirimanna,et al.  Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions , 2011, International journal of audiology.

[26]  H. Kamp,et al.  The individual and combined metabolite profiles (metabolomics) of dibutylphthalate and di(2-ethylhexyl)phthalate following a 28-day dietary exposure in rats. , 2010, Toxicology letters.

[27]  E. Distrutti,et al.  The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity1 , 2009, The Journal of Immunology.

[28]  P. Dent,et al.  Bile acids as regulatory molecules , 2009, Journal of Lipid Research.

[29]  Johan Auwerx,et al.  Targeting bile-acid signalling for metabolic diseases , 2008, Nature Reviews Drug Discovery.

[30]  B. van Ravenzwaay,et al.  The use of metabolomics for the discovery of new biomarkers of effect. , 2007, Toxicology letters.

[31]  Dae-Joong Kang,et al.  Bile salt biotransformations by human intestinal bacteria Published, JLR Papers in Press, November 18, 2005. , 2006, Journal of Lipid Research.

[32]  Takao Nakamura,et al.  Identification of membrane-type receptor for bile acids (M-BAR). , 2002, Biochemical and biophysical research communications.

[33]  M. Haussler,et al.  Vitamin D Receptor As an Intestinal Bile Acid Sensor , 2002, Science.

[34]  R. Evans,et al.  An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Schlüter,et al.  Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone. , 1999, The Journal of antimicrobial chemotherapy.

[36]  C. Nakamura,et al.  Characteristic difference in gastrointestinal excretion of clarithromycin and roxithromycin , 1998, Biopharmaceutics & drug disposition.

[37]  A. Beynen,et al.  The inhibitory effect of carboxymethylcellulose with high viscosity on lipid absorption in broiler chickens coincides with reduced bile salt concentration and raised microbial numbers in the small intestine. , 1998, Poultry science.

[38]  J. Riviere,et al.  Comparative pharmacokinetics of aminoglycoside antibiotics. , 1991, Journal of veterinary pharmacology and therapeutics.

[39]  M. Corada,et al.  Toxicity, uptake, and subcellular distribution in rat hepatocytes of roxithromycin, a new semisynthetic macrolide, and erythromycin base , 1988, Antimicrobial Agents and Chemotherapy.

[40]  M. Eastwood,et al.  The dietary effects of sodium carboxymethylcellulose in man , 1986 .

[41]  M. Riottot,et al.  Increase in the ileal absorption rate of sodium taurocholate in germ-free or conventional rats given an amylomaize-starch diet , 1985, British Journal of Nutrition.

[42]  K. Reilly,et al.  Erythromycin, lincomycin, and clindamycin. , 1983, Pediatric clinics of North America.

[43]  J. Gray,et al.  The oral toxicity of clindamycin in laboratory animals. , 1972, Toxicology and applied pharmacology.

[44]  J. Mathews,et al.  Ultrastructural studies of the hepatic changes brought about by Clindamycin and Erythromycin in animals. , 1971, Toxicology and applied pharmacology.

[45]  J. Gray,et al.  Further toxicologic studies of lincomycin , 1966 .

[46]  J. Gray,et al.  ANIMAL TOXICITY STUDIES OF A NEW ANTIBIOTIC, LINCOMYCIN. , 1964, Toxicology and applied pharmacology.

[47]  J. Geraci,et al.  Some laboratory and clinical experiences with a new antibiotic, vancomycin. , 1956, Proceedings of the staff meetings. Mayo Clinic.

[48]  M. Delaforge,et al.  In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin. , 1988, Chemico-biological interactions.